TITLE

Selecting patients for randomized trials: a systematic approach based on risk group

AUTHOR(S)
Vickers, Andrew J.; Kramer, Barry S.; Baker, Stuart G.
PUB. DATE
January 2006
SOURCE
Trials;2006, Vol. 7, p30
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: A key aspect of randomized trial design is the choice of risk group. Some trials include patients from the entire at-risk population, others accrue only patients deemed to be at increased risk. We present a simple statistical approach for choosing between these approaches. The method is easily adapted to determine which of several competing definitions of high risk is optimal. Method: We treat eligibility criteria for a trial, such as a smoking history, as a prediction rule associated with a certain sensitivity (the number of patients who have the event and who are classified as high risk divided by the total number patients who have an event) and specificity (the number of patients who do not have an event and who do not meet criteria for high risk divided by the total number of patients who do not have an event). We then derive simple formulae to determine the proportion of patients receiving intervention, and the proportion who experience an event, where either all patients or only those at high risk are treated. We assume that the relative risk associated with intervention is the same over all choices of risk group. The proportion of events and interventions are combined using a net benefit approach and net benefit compared between strategies. Results: We applied our method to design a trial of adjuvant therapy after prostatectomy. We were able to demonstrate that treating a high risk group was superior to treating all patients; choose the optimal definition of high risk; test the robustness of our results by sensitivity analysis. Our results had a ready clinical interpretation that could immediately aid trial design. Conclusion: The choice of risk group in randomized trials is usually based on rather informal methods. Our simple method demonstrates that this decision can be informed by simple statistical analyses.
ACCESSION #
30095535

 

Related Articles

  • Randomized Controlled Trials. Torpy, Janet M. // JAMA: Journal of the American Medical Association;3/24/2010, Vol. 303 Issue 12, p1216 

    The article offers information on randomized controlled trials. Randomized controlled trial is a type of clinical trial where study participants are randomly assigned to receive treatment, in an effort to determine outcomes based on the treatment and not by other factors. Clinical trials are...

  • The Tissue Selective Estrogen Complex: A Promising New Menopausal Therapy. Komm, Barry S.; Mirkin, Sebastian // Pharmaceuticals;Sep2012, Vol. 5 Issue 9, p899 

    Menopause is associated with health concerns including vasomotor symptoms, vulvar/vaginal atrophy (VVA), and osteoporosis. Estrogen therapy or combined estrogen-progestin therapy (EPT) are primary treatment options for menopausal symptom relief and osteoporosis prevention. Because EPT has been...

  • Developing a survey of barriers and facilitators to recruitment in randomized controlled trials. Kaur, Geetinder; Smyth, Rosalind L.; Williamson, Paula // Trials;2012, Vol. 13 Issue 1, p1 

    Background: Recruitment to randomized controlled trials is known to be challenging. It is important to understand and identify predictors of good or poor accrual to a clinical trial so that appropriate strategies can be put in place to overcome these problems and facilitate successful trial...

  • The new CONSORT statement. Antes, Gerd // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;3/27/2010, Vol. 340 Issue 7748, p666 

    The author supports the 2010 update of the CONSORT statement. The statement, issued in 1996, offered suggestions for the publication of randomized controlled clinical trials, the standard to assess healthcare interventions. The findings of a comparative study by S. Hopewell and colleagues are...

  • How to mislead people with clinical trials. Ernst, Edzard // Biologist;Nov2008, Vol. 55 Issue 4, p215 

    The article discusses the ways in which people can be misled through the findings of clinical trials. Reliability in clinical trials is the extent to which repeated experiments agree with each other. Bias renders the results of clinical trials unreliable, and rigorous clinical trials are...

  • Study to Test Exercise in Heart Failure Patients.  // IDEA Fitness Journal;May2007, Vol. 4 Issue 5, p15 

    This article announces that a randomized clinical trial of exercise training is underway which will involve 83 sites that will test 3,000 people to find out whether exercise is good for hearth failure patients. It says that health and fitness promoters may benefit from this undertaking. Delane...

  • No differences in outcomes between cemented and uncemented acetabular components after 12–14 years: results from a randomized controlled trial comparing Duraloc with Charnley cups.  // Journal of Orthopaedics & Traumatology;Mar2010, Vol. 11 Issue 1, p37 

    The article presents a study on the long-term clinical and radiographic outcome and component survival in a randomized controlled trial. A total of 215 patients were allocated to receive a cemented Charnley cup or uncemented Duraloc 1200 cup. After ten years, there is no statistically...

  • The reality of undertaking research in podiatry: challenges and experiences of two clinical podiatry researchers. Etoria-King, Hazel; Amor, Tim; Deehan, Ann // Podiatry Now;May2009, Vol. 12 Issue 5, p30 

    The article offers a look at the practical experiences of two clinical podiatrists in undertaking a randomized controlled trial (RCT) within a hospital environment while on secondment from their primary care trust (PCT) clinical commitments. The challenges posed by recruiting trial participants...

  • Sorry, you're barred. Iheanacho, Ike // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/3/2009, Vol. 338 Issue 7685, p56 

    In this article the author discusses individuals who have been barred from participating in clinical studies. He is critical of the criteria that are used to determine whether a person is selected to participate in a clinical study. Also discussed are mechanisms that are in place to prevent...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics